Press release
Liposome Drug Delivery Market to hit USD 6,992.95 million, Globally, by 2027 at 8.8% CAGR: The Insight Partners
Liposome Drug Delivery Market
Liposomes are rapidly gaining acceptance as nano-carriers for various pharmaceutical applications. Compositions of cholesterol and phospholipids are becoming increasingly useful in liposome drug delivery. As the nanoscience is optimizing liposome drug delivery, the pharmaceutical and biotechnology companies are exploring alternative compositions with cholesterol, as well as new techniques such as nanotechnology, to improve the stability and drug release profiles with the help of encapsulation and other methods. They are using liposomes for the generation of extracellular vesicles by targeted cells. Manufacturers in the liposome drug delivery market are ramping up their R&D activities for unlocking new lipid compositions and strategies that help optimize the drug transport and stability of liposomes. Similar experiments for innovative liposome fabrication are likely to offer growth opportunities for the market players to attain a significant position and grow in the liposome drug delivery market.
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis - https://www.theinsightpartners.com/sample/TIPRE00010407/?utm_source=OpenPR&utm_medium=10408
North America held the largest share of the liposome drug delivery market. The burgeoning penetration of nanotechnology in drug delivery systems translated into commercially viable products is likely to be responsible for the dominance of the market. Furthermore, the presence of key market leaders in the region investing huge amounts in R&D of new drug delivery channels to improve the efficacy of drugs are expected to come up with novel liposomal solutions in the near future securing potential growth in the market. On the other hand, Asia Pacific is currently a niche market and has high potential for growth, which is attributed to the increasing number of patients with chronic diseases and growing R&D spending by pharmaceutical giants in the region, thereby opening opportunities for developing robust pipeline for liposomal drugs. In addition, the rising disposable incomes among Asian population leading to increasing awareness toward healthy lifestyle is likely to propel the market growth.
Leading companies operating in the liposome drug delivery market are Takeda Pharmaceutical Company Limited, Novartis AG, Luye Pharma Group, Ipsen Pharma, Celsion, Inc., Gilead Sciences, Inc., Astellas Pharma, Inc., Johnson & Johnson Services, Inc., and Acrotech Biopharma, Inc.
Have a 15-minute-long discussion with the lead analyst and author of the report in a time slot decided by you. You will be briefed about the contents of the report and queries regarding the scope of the document will be addressed as well - https://www.theinsightpartners.com/speak-to-analyst/TIPRE00010407?utm_source=OpenPR&utm_medium=10408
The report analyzes Liposome Drug Delivery Market on the basis of following segments:
By Product
Liposomal Doxorubicin
Liposomal Paclitaxel
Liposomal Amphotericin B
Others
By Technology
Stealth Liposome Technology
Non-PEGylated Liposome Technology
DepoFoam Liposome Technology
Lysolipid Thermally Sensitive Liposome (LTSL) Technology
By Application
Fungal Diseases
Cancer Therapy
Pain Management
Viral Vaccines
Photodynamic Therapy
By Geography
North America
US
Canada
Mexico
Europe
France
Germany
UK
Spain
Italy
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Middle East and Africa
Saudi Arabia
UAE
South Africa
South and Central America
Brazil
Argentina
Immediate delivery of our off-the-shelf reports and prebooking of upcoming studies, through flexible and convenient payment methods -
https://www.theinsightpartners.com/buy/TIPRE00010407/?utm_source=OpenPR&utm_medium=10408
Contact Us
If you have any queries about this report or would like further information, please contact us:
North America: +1 646 491 9876
Asia-Pacific: +91 20 6727 8686
Email: sales@theinsightpartners.com
About The Insight Partners
The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Healthcare, Media, and Telecommunication.
Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis.
Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, products, applications, end users etc., which helps our clients to gain a deeper analytical understanding of various research topics.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liposome Drug Delivery Market to hit USD 6,992.95 million, Globally, by 2027 at 8.8% CAGR: The Insight Partners here
News-ID: 2623180 • Views: …
More Releases from The Insight Partners
Contactor Market Analysis 2031: EV Boom, Automation Trends, and Key Players
New York, US - December 12, 2025 - The Insight Partners has announced the publication of its latest market research report titled "Contactor Market Forecast to 2031." The report reveals that the global Contactor Market is projected to grow at a CAGR of 6.3% from 2025 to 2031, expanding from US$ XX million in 2024 to US$ XX million by 2031. This growth is driven by the rapid rise in…
Joint Reconstruction Devices Market to Reach US$ 39.87 Billion by 2031
The Global Joint Reconstruction Devices Market is on a steady growth trajectory, underpinned by rising musculoskeletal disorders, a growing elderly population, and expanding access to advanced orthopaedic surgery worldwide. As patients increasingly expect to maintain active, independent lives, joint reconstruction devices are helping restore mobility and quality of life after arthritis, injury, or degenerative disease.
The joint reconstruction devices market size is projected to reach US$ 39.87 billion by 2031 from…
Global Bio Based Paraxylene Market Set for Robust Growth Driven by Sustainable P …
New York, US, [12- December-2025] - The global Bio-Based Paraxylene (Bio-PX) Market is witnessing strong momentum as industries worldwide accelerate the transition toward renewable chemicals and sustainable packaging solutions. With rising demand for bio-based PET (polyethylene terephthalate), stringent carbon reduction targets, and growing investments in green chemistry, the market for Bio-PX is projected to achieve impressive growth over the forecast period.
Request Sample Pages of this Research Study at -
https://www.theinsightpartners.com/sample/TIPRE00019198?utm_source=OpenPR&utm_medium=10812
Bio-based…
Histology Equipment Market Research Report Covering Prime Factors and Competitiv …
Cutting-edge histology equipment is transforming diagnostic pathology, enabling sharper tissue analysis for faster cancer detection and disease insights. Labs worldwide embrace automated microtomes, advanced staining systems, and embedding stations that streamline workflows and boost accuracy. The Histology Equipment Market surges as precision medicine demands reliable tissue processing tools.
Key Market Insights by 2031
Histology equipment powers essential pathology functions, from tissue fixation to slide preparation. Facilities value user-friendly designs that reduce errors…
More Releases for Liposome
Liposome Manufacturing Market to Hit USD 21.8 Billion by 2034
Liposomes are spherical vesicles composed of phospholipid bilayers that encapsulate therapeutic molecules, providing enhanced drug delivery, controlled release, and reduced toxicity. Liposomes are widely used in oncology, vaccines, gene therapy, and dermatology, offering improved bioavailability and targeted delivery for both small molecules and biologics.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72611
The global liposome manufacturing market is expanding due to the growing demand for advanced drug delivery systems, increasing…
Irinotecan Hydrochloride Liposome Injection Market Forecast to 2034
Market Overview
As of 2024, the Irinotecan Hydrochloride Liposome Injection Market is valued at USD 116 million. It is expected to grow at a Compound Annual Growth Rate (CAGR) of 10.1% from 2024 to 2034, reaching approximately USD 305 million by 2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/59123
Key Market Highlights:
• Base Year: 2023
• Forecast Period: 2024-2034
• 2024 Market Size: USD 116 Million
• 2034 Forecasted Size: USD 305 Million
• CAGR: 10.1%
• Primary Driver: Rising prevalence of…
Doxorubicin Hydrochloride Liposome Injection Market Size, Share and Growth Repor …
" The global market for Doxorubicin Hydrochloride Liposome Injection is projected to reach approximately $1.2 billion in 2024. The forecast period from 2025 to 2034 is expected to witness significant expansion, with a projected market value increasing to around $2.5 billion by 2034. This growth represents a Compound Annual Growth Rate (CAGR) of approximately 8.1% during the forecast period, driven by rising incidences of various cancers, advancements in liposomal drug…
Liposome Drug Delivery Market Future Prediction Report By 2031
A new market study report by The Insight Partners on the Liposome Drug Delivery Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period.
Get PDF Sample Report…
Liposome Makeover: How Creative Biolabs is Amping Up Drug Delivery
Creative Biolabs is at the forefront of the liposome "revolution", offering cutting-edge liposome development services tailored to meet the complex needs of researchers and pharmaceutical companies.
New York, USA - September 11, 2024 - As the biotech and pharmaceutical sectors continue their rapid evolution, the demand for innovative and efficient drug delivery systems has reached an all-time high. One of the most promising developments in this field has been the use…
Liposome in Cosmetics Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Liposome in Cosmetics market.
Liposomes are spherical vesicles in which their central aqueous section is surrounded by one or more of a bilayer membrane (Lamella) that is frequently enclosed by aquatic environments. These vesicles are formed when amphiphilic lipids confront with aqueous milieu. They can vary in size from 15 nm to several microns. In the…
